March 24, 2021
Chugai Pharmaceutical said on March 23 that it has received Japanese approval for FoundationOne Liquid CDx Cancer Genomic Profile, the first blood-based comprehensive genomic profiling test for solid tumors in Japan. The product was also approved for use as a...read more